PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCANTUZUMAB RAVTANSINE
CANTUZUMAB RAVTANSINE
Cantuzumab ravtansine is an antibody drug conjugate pharmaceutical. It is currently being investigated in clinical studies. It is known to target mucin-1.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
2 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Stomach neoplasmsD013274EFO_0003897C1611
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Colorectal neoplasmsD01517911
Pancreatic neoplasmsD010190EFO_0003860C2511
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCANTUZUMAB RAVTANSINE
INNcantuzumab ravtansine
Description
Cantuzumab Ravtansine (humanized mab)
Classification
Antibody
Drug classmonoclonal antibodies; maytansinoid derivatives
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL1742998
ChEBI ID
PubChem CID
DrugBank
UNII IDRNQ8JQ4R9P (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
MUC1
MUC1
Organism
Homo sapiens
Gene name
MUC1
Gene synonyms
PUM
NCBI Gene ID
Protein name
mucin-1
Protein synonyms
Breast carcinoma-associated antigen DF3, CA 15-3, Cancer antigen 15-3, Carcinoma-associated mucin, CD227, EMA, Episialin, H23 antigen, H23AG, KL-6, Krebs von den Lungen-6, mucin 1, transmembrane, Peanut-reactive urinary mucin, PEM, PEMT, Polymorphic epithelial mucin, PUM, tumor associated epithelial mucin, Tumor-associated epithelial membrane antigen, Tumor-associated mucin
Uniprot ID
Mouse ortholog
Muc1 (17829)
mucin-1 (Q02496)
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use